Nile Pharma’s OGM approves dividends distribution of EGP 2.97/share
Updated 10/16/2022 12:05:50 PM
Arab Finance: The ordinary general meeting (OGM) of El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) approved the distribution of cash dividends worth EGP 2.97 per share to shareholders for fiscal year (FY) 2021/2022, according to a statement on October 16th.
The company previously reported a 39.19% year-on-year (YoY) increase in net profits for FY 2021/2022, recording net profits of EGP 89.67 million, compared to EGP 64.42 million in the FY before.
Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.
